A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Arvinas Inc.
Arvinas Inc.
Novartis
AstraZeneca
Revolution Medicines, Inc.
Tempus AI
Travera Inc
Palleon Pharmaceuticals, Inc.
Eli Lilly and Company
Tempus AI
Vyriad, Inc.
VitaMed Research LLC
ADC Therapeutics S.A.
Klus Pharma Inc.
Kineta Inc.
Genzada Pharmaceuticals USA, Inc.
Provectus Pharmaceuticals
TScan Therapeutics, Inc.
MacroGenics
SpeciCare
Asana BioSciences
Sichuan Huiyang Life Science and Technology Corporation
MedInnovation GmbH
Novartis
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc
Calando Pharmaceuticals
Delcath Systems Inc.
Altor BioScience
GammaCan